A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...

A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...

Molecular profiling and genetic testing have revolutionised lung cancer treatment, says a doctor. They have enabled targeted ...

Here we present a case of a patient with stage IV CD-74-ROS1 fusion NSCLC discovered initially with RNA next generation sequencing (NGS) who acquired ...

Though smoking and increasing levels of pollution exposure are well recognised as causes of lung cancer the connection ...

The following is a summary of “Sex-based differences in lung cancer susceptibility and molecular genetics in the 2020s,” published in the January 2025 issue of Pulmonology by Mosleh et al. Sex-based ...

Lung cancer in people who have never smoked is rising, and figures show China is at particular risk of air pollution-related cancer Despite drops in tobacco use worldwide, the incidence of lung cancer ...

Explore how genetic testing and precision oncology are revolutionizing cancer treatment by offering personalized care and ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled "Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 ...

As discussed in the beginning, in some cases lung cancer can spread to other parts of the body such as the brain, liver, and bones. While smoking poses the highest risk, long-term exposure to air ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the subcutaneous (SC) formulation be approved ...